Sana Biotechnology is focused on utilizing engineered cells as medicines for patients. The ability to modify genes and use cells as medicines will be one of the most important advances in healthcare over the next several decades.  Sana is building differentiated capabilities across the spectrum of cell and gene therapy. 

Biotechnology

Sana Biotechnology

Steve Harr

Ian Lauf

Kunjan Desai

Paul Brunetta

Douglas E. Williams

Gary Meininger

Snehal Patel

Bernard J. Cassidy

Terry Fry

Nate Hardy

Sonja Schrepfer

Research and Development Team

Leadership Team

Information Technology Team

Engineering Team

Finance and Accounting Team

Clinical Operations Team

Legal and Compliance Team

Teams at Sana Biotechnology